Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
HGF elevation
i
Other names:
HGF, DFNB39, F-TCF, HGFB, HPTA, SF, Hepatocyte growth factor (hepapoietin A; scatter factor)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3082
Related biomarkers:
Expression
Mutation
CNA
Others
‹
HGF-L (3)
BRAF wild-type + HGF elevation (1)
HGF elevation + VEGFA elevation (1)
IL6 elevation + HGF elevation + CCL8 elevation (1)
RAS wild-type + HGF elevation (1)
HGF elevation (0)
HGF-L (3)
BRAF wild-type + HGF elevation (1)
HGF elevation + VEGFA elevation (1)
IL6 elevation + HGF elevation + CCL8 elevation (1)
RAS wild-type + HGF elevation (1)
HGF elevation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
HGF elevation
Hepatocellular Cancer
HGF elevation
Hepatocellular Cancer
cabozantinib tablet
Resistant: B - Late Trials
cabozantinib tablet
Resistant
:
B
cabozantinib tablet
Resistant: B - Late Trials
cabozantinib tablet
Resistant
:
B
HGF elevation
Pancreatic Ductal Adenocarcinoma
HGF elevation
Pancreatic Ductal Adenocarcinoma
Resistant: C3 – Early Trials
Resistant
:
C3
Resistant: C3 – Early Trials
Resistant
:
C3
HGF elevation
Renal Cell Carcinoma
HGF elevation
Renal Cell Carcinoma
pazopanib
Resistant: C3 – Early Trials
pazopanib
Resistant
:
C3
pazopanib
Resistant: C3 – Early Trials
pazopanib
Resistant
:
C3
HGF elevation
Renal Cell Carcinoma
HGF elevation
Renal Cell Carcinoma
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
HGF elevation
Renal Cell Carcinoma
HGF elevation
Renal Cell Carcinoma
sunitinib + pazopanib
Resistant: C3 – Early Trials
sunitinib + pazopanib
Resistant
:
C3
sunitinib + pazopanib
Resistant: C3 – Early Trials
sunitinib + pazopanib
Resistant
:
C3
HGF elevation
Melanoma
HGF elevation
Melanoma
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
HGF elevation
Renal Cell Carcinoma
HGF elevation
Renal Cell Carcinoma
cabozantinib tablet
Resistant: C3 – Early Trials
cabozantinib tablet
Resistant
:
C3
cabozantinib tablet
Resistant: C3 – Early Trials
cabozantinib tablet
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login